Latest Breaking News On - Partnerat jeito - Page 1 : comparemela.com

About Jeito Capital Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients’ access in Europe & the United States. Jeito Capital is based in Paris with a presence in Europe and the United States. For more information, please visit www.jeito.life, or follow on Twitter @Jeito life or LinkedIn. About Pulmocide Pulmocide Ltd (www.pulmocide.com) is a late-stage biopharmaceutical company developing novel therapies for patients suffering from serious acute and chronic respiratory diseases. Pulmocide’s lead product is PC945, a novel antifungal specifically designed for inhaled use to maximize the amount of drug in the lung

United statesFrance generalSabine dandiguianDan burgessAsahi kasei pharmaPartnerat jeitoSv health investorsPulmocide ltdConsilium strategic communicationsJeito capitalPrivate equityAdjuvant capitalF prime capitalJohnson innovationManaging partnerInvasive pulmonary aspergillosis